封面
市場調查報告書
商品編碼
1712512

全球可互通醫療資訊科技(健康IT)系統市場-2025-2033

Global Interoperable Healthcare Information Technology (Health IT) Systems Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 165 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球可互通醫療資訊科技 (Health IT) 系統市場規模達到 30.8 億美元,預計到 2033 年將達到 231.8 億美元,在 2025-2033 年預測期內的複合年成長率為 22.3%。

可互通的醫療保健資訊技術 (Health IT) 系統是促進不同提供者、機構和 IT 系統之間安全、無縫和標準化地交換醫療保健資料的數位平台。這些系統實現了 EHR、實驗室系統、影像系統和藥房系統等各種技術的有效協作。醫療保健領域互通性的主要目標是透過提供準確、最新的醫療資訊來改善病患照護。可互操作系統支援更好的協調,減少測試重複,增強決策能力,並透過整個醫療保健生態系統的有效溝通和協作改善醫療保健結果。執行摘要

市場動態:

駕駛員和約束裝置

無縫患者資料交換需求日益成長

可互通醫療 IT 系統市場受到跨醫療環境無縫患者資料交換需求的驅動,從而實現更快、更協調的護理。這些解決方案改善了臨床決策並減少了醫療錯誤。政府的授權和激勵措施,特別是在北美和歐洲等已開發市場,支持推動互聯醫療系統的發展。

隨著對這些解決方案的需求不斷成長,該公司正在推出先進的醫療保健 IT 解決方案。例如,2025 年 3 月,eHealth Technologies 在 FHIR 上推出了 eHealth Connect,這是一種與領先的 EHR 提供者整合的醫療保健技術解決方案。這種整合基於行業標準快速醫療互通性資源 (FHIR),可實現醫療系統之間安全、即時的資料交換。 eHealth Connect平台為兩個平台之間的醫療記錄檢索提供了無縫連接。

實施和整合成本高

實施可互通的醫療保健 IT 系統的高成本對於中小型醫療保健提供者來說是一個重大障礙,因為他們面臨系統升級、基礎設施變更和員工培訓的前期投資。將遺留系統與現代平台整合的複雜性也會限制其廣泛採用,尤其是在新興市場。

目錄

第1章:市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第2章:高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按類型分類的程式碼片段
  • 按互通性等級分類的程式碼片段
  • 以部署方法分類的程式碼片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第3章:動態

  • 影響因素
    • 驅動程式
      • 無縫患者資料交換需求日益成長
      • 政府措施和法規
    • 限制
      • 實施和整合成本高
      • 資料隱私和安全問題
    • 機會
      • 醫療保健 IT 和基礎設施的投資不斷成長。
    • 影響分析

第4章:戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大、最暢銷品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析:最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第5章:依類型

  • 解決方案
  • 服務

第6章:依互通性級別

  • 基礎互通性
  • 結構互通性
  • 語意互通性

第7章:依部署方法

  • 基於雲端
  • 本地部署

第 8 章:按應用

  • 診斷
  • 治療
  • 其他

第 9 章:按最終用戶

  • 醫院
  • 門診手術中心
  • 其他

第10章:區域市場分析與成長機會

  • 北美洲
    • 關鍵區域特定動態
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 關鍵區域特定動態
      • 德國
      • 英國
      • 法國
      • 西班牙
      • 義大利
      • 歐洲其他地區
  • 拉丁美洲
    • 關鍵區域特定動態
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地區
  • 亞太
    • 關鍵區域特定動態
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太其他地區
  • 中東和非洲
    • 關鍵區域特定動態

第 11 章:競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第12章:公司簡介

  • Infor (Koch Industries Inc)
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 併購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT分析
  • Koninklijke Philips NV
  • Cerner Corporation (Oracle Health)
  • Orion Health Group Limited
  • NXGN Management, LLC (NextGen Healthcare)
  • OSP Labs
  • Epic Systems Corporation
  • ViSolve Inc
  • InterSystems Corporation
  • iNTERFACEWARE Inc

第13章:假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 14 章:附錄

簡介目錄
Product Code: HCIT9505

The global interoperable healthcare information technology (Health IT) Systems market reached US$ 3.08 billion in 2024 and is expected to reach US$ 23.18 billion by 2033, growing at a CAGR of 22.3% during the forecast period 2025-2033.

Interoperable Healthcare Information Technology (Health IT) Systems are digital platforms that facilitate the secure, seamless, and standardized exchange of healthcare data across various providers, institutions, and IT systems. These systems enable the effective collaboration of various technologies like EHRs, lab systems, imaging systems, and pharmacy systems. The primary goal of interoperability in healthcare is to improve patient care by providing accurate, up-to-date medical information. Interoperable systems support better coordination, reduce test duplication, enhance decision-making, and improve healthcare outcomes through efficient communication and collaboration across the healthcare ecosystem. Executive Summary

Market Dynamics: Drivers & Restraints

Rising Need for Seamless Patient Data Exchange

The interoperable healthcare IT systems market is driven by the need for seamless patient data exchange across healthcare settings, enabling faster and more coordinated care. These solutions improve clinical decision-making and reduce medical errors. Government mandates and incentives, particularly in developed markets like North America and Europe, support the push for connected health systems.

With the rising demand for these solutions, companies are launching advanced healthcare IT solutions. For instance, in March 2025, eHealth Technologies launched eHealth Connect on FHIR, a healthcare technology solution that integrates with leading EHR providers. This integration, based on the industry standard Fast Healthcare Interoperability Resources (FHIR), enables secure, real-time data exchange between health systems. The eHealth Connect platform provides a seamless connection for medical record retrieval between the two platforms.

High Implementation and Integration Costs

The high cost of implementing interoperable healthcare IT systems is a significant barrier for small and mid-sized healthcare providers, who face upfront investments for system upgrades, infrastructure changes, and staff training. The complexity of integrating legacy systems with modern platforms can also limit widespread adoption, especially in emerging markets.

Segment Analysis

The global interoperable healthcare information technology (Health IT) systems market is segmented based on type, level of interoperability, deployment method, application, end-user, and region.

Type:

The solutions from the type segment are expected to dominate the interoperable healthcare information technology (Health IT) systems market, with the highest market share

The interoperable healthcare IT systems market focuses on digital platforms, software, and tools that facilitate seamless data sharing and integration across various healthcare systems and providers. These solutions include electronic health record (EHR) interoperability systems, health information exchanges (HIEs), and enterprise data integration tools. The aim is to ensure secure and accurate medical information flow, improve patient outcomes, and reduce redundant procedures, supporting coordinated care.

The interoperable healthcare IT systems market is expanding due to global demand for connected systems, the adoption of interoperability solutions to reduce information silos, improve care transitions, and minimize clinical errors, government mandates and incentive programs in North America and Europe, and the rise in chronic disease prevalence, increasing healthcare data volumes, and the need for efficient medical data exchange in emergencies.

For instance, in February 2025, Edifecs, a global health information technology solutions company, launched its Healthcare Interoperability Cloud. This tool allows payers to strategically manage interoperability and compliance with CMS-9115-F and CMS-0057-F standards. Edifecs was identified as the leading partner for both FHIR and EDI solutions in a study of 99 payers. Since 1996, Edifecs has been instrumental in defining interoperability standards. These factors contribute to the growth of interoperable health IT solutions in the healthcare ecosystem.

Geographical Analysis

North America is expected to hold a significant position in the interoperable healthcare information technology (health IT) systems market with the highest market share

North America is experiencing significant growth in the interoperable healthcare IT systems market, driven by government initiatives, novel platform launches, advanced infrastructure, and high adoption of electronic health records. Regulations like the HITECH Act and the 21st Century Cures Act in the US encourage interoperable systems for secure data exchange. The region also benefits from investments in digital health, supportive reimbursement models, and value-based care. Major health IT companies and the widespread use of mobile health technologies contribute to the demand for interoperability solutions in healthcare settings.

For instance, in March 2025, CommonWell Health Alliance launched the CommonWell Marketplace, a platform aimed at enhancing interoperability and patient care by connecting healthcare providers with innovative solutions, enabling organizations to optimize their nationwide health data exchange priorities.

Competitive Landscape

The major global players in the interoperable healthcare information technology (Health IT) systems market include Infor (Koch Industries Inc), Koninklijke Philips N.V., Cerner Corporation (Oracle Health), Orion Health Group Limited, NXGN Management, LLC (NextGen Healthcare), OSP Labs, Epic Systems Corporation, ViSolve Inc, InterSystems Corporation, and iNTERFACEWARE Inc among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global interoperable healthcare information technology (Health It) systems market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Level of Interoperability
  • 2.5. Snippet by Deployment Method
  • 2.6. Snippet by Application
  • 2.7. Snippet by End User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Need for Seamless Patient Data Exchange
      • 3.1.1.2. Government Initiatives and Regulations
    • 3.1.2. Restraints
      • 3.1.2.1. High Implementation and Integration Costs
      • 3.1.2.2. Data Privacy and Safety Concerns
    • 3.1.3. Opportunity
      • 3.1.3.1. Growing Investment in Healthcare IT and Infrastructure.
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Solutions*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Services

6. By Level of Interoperability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 6.1.2. Market Attractiveness Index, By Level of Interoperability
  • 6.2. Foundational Interoperability*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Structural Interoperability
  • 6.4. Semantic Interoperability

7. By Deployment Method

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 7.1.2. Market Attractiveness Index, By Deployment Method
  • 7.2. Cloud-Based*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. On-Premise

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Diagnosis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Treatment
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. Latin America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of Latin America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Infor (Koch Industries Inc) *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals, etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Koninklijke Philips N.V.
  • 12.3. Cerner Corporation (Oracle Health)
  • 12.4. Orion Health Group Limited
  • 12.5. NXGN Management, LLC (NextGen Healthcare)
  • 12.6. OSP Labs
  • 12.7. Epic Systems Corporation
  • 12.8. ViSolve Inc
  • 12.9. InterSystems Corporation
  • 12.10. iNTERFACEWARE Inc

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us